Efficient aerobic oxidative synthesis of 2-substituted benzoxazoles, benzothiazoles, and benzimidazoles catalyzed by 4-Methoxy-TEMPO

Angewandte Chemie - International Edition

Volumn 47, Issue 48, 2008, Pages 9330-9333

  Chen, Yong Xing ^a   Qian, Ling Feng ^a   Zhang, Wei ^a   Han, Bing ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Aerobic oxidation; Cyclization; Heterocycles; Synthetic methods

Indexed keywords

CHEMICAL REACTIONS; FREE RADICALS;

AEROBIC OXIDATION; BENZIMIDAZOLES; BENZOTHIAZOLES; BENZOXAZOLES; CHEMICAL EQUATIONS; HETEROCYCLES; METHOXY; SYNTHESIS OF; SYNTHETIC METHODS; TETRA METHYLS;

SYNTHESIS (CHEMICAL);

EID: 56449089532     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200803381     Document Type: Article

References (41)

1. For reviews, see: a) Y. Ishii, S. Sakaguchi, T. Iwahama, Adv. Synth. Catal. 2001, 343, 393-427;
2. b) F. Recupero, C. Punta, Chem. Rev. 2007, 107, 3800-3842;
3. c) R. A. Sheldon, I. W. C. E. Arends, Adv. Synth. Catal. 2004, 346, 1051-1071;
4. d) R. A. Sheldon, I. W. C. E Arends, G.-J. Brink, A. Dijksman, Acc. Chem. Res. 2002, 35, 774-781;
5. e) C. Galli, P. Gentili, O. Lanzalunga, Angew. Chem. 2008, 120, 4868-4874;
6. Angew. Chem. Int. Ed. 2008, 47, 4790-4796;
7. f) T. Vogler, A. Studer, Synthesis 2008, 1979-1993;
8. g) J. Piera, Jan-E. Bäckvall, Angew. Chem. 2008, 120, 3558-3576;
9. Angew. Chem. Int. Ed. 2008, 47, 3506-3523.
10. For examples in medicinal chemistry, see: a) M. L. McKee, S. M. Kerwin, Bioorg. Med. Chem. 2008, 16, 1775-1783;
11. b) E. Oksuzoglu, O. Temiz-Arpaci, B. Tekiner-Gulbas, H. Eroglu, G. Sen, S. Alper, I. Yildiz, N. Diril, E. Aki-Sener, I. Yalcin, Med. Chem. Res. 2008, 16, 1-14;
12. c) S.-T. Huang, I.-J. Hsei, C. Chen, Bioorg. Med. Chem. 2006, 14, 6106-6119;
13. d) C. G. Mortimer, G. Wells, J.-P. Crochard, E. L. Stone, T. D. Bradshaw, M. F. G. Stevens, A. D. Westwell, J. Med. Chem. 2006, 49, 179-185;
14. e) M. C. Van Zandt, M. L. Jones, D. E. Gunn, L. S. Geraci, J. H. Jones, D. R. Sawicki, J. Sredy, J. L. Jacot, A. T. DiCioccio, T. Petrova, A. Mitschler, A. D. Podjarny, J. Med. Chem. 2005, 48, 3141-3152;
15. f) M. Hranjec, M. Kralj, I. Piantanida, M. Sedic, L. Suman, K. Pavelic, G. Karminski-Zamola, J. Med. Chem. 2007, 50, 5696-5711;
16. g) M. L. Morningstar, T. Roth, D. W. Farnsworth, M. Kroeger Smith, K. Watson, R. W. Buckheit, Jr., K. Das, W. Zhang, E. Arnold, J. G. Julias, S. H. Hughes, C. J. Michejda, J. Med. Chem. 2007, 50, 4003-4015.
17. D. C. Tully, H. Liu, P. B. Alper, A. K. Chatterjee, R. Epple, M. J. Roberts, J. A. Williams, K. T. Nguyen, D. H. Woodmansee, C. Tumanut, J. Li, G. Spraggon, J. Chang, T. Tuntland, J. L. Harris, D. S. Karanewsky, Bioorg. Med. Chem. Lett. 2006, 16, 1975-1980.
18. J. A. Grobler, G. Dornadula, M. R. Rice, A. L. Simcoe, D. J. Hazuda, M. D. Miller, J. Biol. Chem. 2007, 282, 8005-8010.
19. J. Easmon, G. Pürstinger, K.-S. Thies, G. Heinisch, J. Hofmann, J. Med. Chem. 2006, 49, 6343-6350.
20. K. Rasmussen, M.-A. Hsu, Y. Yang, Neuropsychopharmacology 2007, 32, 786-792.
21. a) R. D. Viirre, G. Evindar, R. A. Batey, J. Org. Chem. 2008, 73, 3452-3459;
22. b) G. Evindar R. A. Batey, J. Org. Chem. 2006, 71, 1802-1808;
23. c) G. Altenhoff, F. Glorius, Adv. Synth. Catal. 2004, 346, 1661-1664.
24. M. Terashima, M. Ishii, Y. Kanaoka, Synthesis 1982, 484-485.
25. J. Chang, K. Zhao, S. Pan, Tetrahedron Lett. 2002, 43, 951-954.
26. R. S. Varma, R. K. Saini, O. Prakash, Tetrahedron Lett. 1997, 38, 2621-2622.
27. K. H. Park, K. Jun, S. R. Shin, S. W. Oh, Tetrahedron Lett. 1996, 37, 8869-8870.
28. C. Praveen, K. H. Kumar, D. Muralidharan, P. T. Perumal, Tetrahedron 2008, 64, 2369-2374.
29. R. G. Srivastava, P. S. Venkataramani, Synth. Commun. 1988, 18, 1537-1544.
30. Y. Kawashita, N. Nakamichi, H. Kawabata, M. Hayashi, Org. Lett. 2003, 5, 3713-3715.
31. M. Kidwai, V. Bansal, A Saxena, S. Aerryb, S. Mozumdar, Tetrahedron Lett. 2006, 47, 8049-8053.
32. a) B. Han, Q. Liu, Z.-G. Liu, R.-Z. Mu, W. Zhang, Z.-L. Liu, W. Yu, Synlett 2005, 2333-2334;
33. b) B. Han, Z.-G. Liu, Q. Liu, L. Yang, Z.-L. Liu, W. Yu, Tetrahedron 2006, 62, 2492-2496.
34. a) X. Wang, R. Liu, Y. Jin, X. Liang, Chem. Eur. J. 2008, 14, 2679-2685;
35. b) R. Liu, X. Liang, C. Dong, X. Hu, J. Am. Chem. Soc. 2004, 126, 4112-4113.
36. It is well known that two kinds of resonance structures for TEMPO exist (I and II). The structures result from the unpaired electron delocalized between the nitrogen and the oxygen atoms. The greater the solvent polarity, the more favored structure II will be, as it has the larger electron density on the oxygen atom and spin density on the nitrogen atom. Structure II should reduce the hydrogen abstraction reactivity of TEMPO with phenols. Otherwise, the hydrogen-bonding interaction of TEMPO with protic solvents should disturb the interaction between TEMPO and phenols. See: a) P. Franchi, M. Marco Lucarini, P. Pedrielli, G. F. Pedulli, ChemPhysChem 2002, 3, 789-793, and references therein;
37. b) L. R. C. Barclay, C. E. Edwards, M. R. Vinqvist, J. Am. Chem. Soc. 1999, 121, 6226-6231. (Chemical Equation Presented)
38. The intermolecular hydrogen-bonding interaction between TEMPO and phenol has been studied both in solution and solid state. For solution studies, see: a) I. G. Shenderovich, Z. Kecki, I. Wawer, G. S. Denisov, Spectrosc. Lett. 1997, 30, 1515-1523;
39. for solid-state studies the single crystal structure of TEMPO·phenol adduct was obtained, see: b) B. Ahrens, M. G. Davidson, V. T. Forsyth, M. F. Mahon, A. L. Johnson, S. A. Mason, R. D. Price, P. R. Raithby, J. Am. Chem. Soc. 2001, 123, 9164-9165.
40. For the hydrogen absraction between TEMPO and phenols, see: a) C. Aliaga, A. Aspée, J. C. Scaiano, Org. Lett. 2003, 5, 4145-4148;
41. b) C. Aliaga, J. M. Jua'rez-Ruiz, J. C. Scaiano, A. Aspée, Org. Lett. 2008, 10, 2147-2150.